Total raised
$5.5M
Last: Series A 2022-08
Stage
Series A
Founded
2018
Headcount
39
HQ
Zikhron Ya'akov
Sector
Health Tech & Life Sciences
About
MyOr provides noninvasive monitoring technologies that use data-driven artificial intelligence to predict and prevent chronic conditions. The company has developed a cutting-edge AI-driven platform designed to predict and mitigate the risk of food allergies, eczema, and related conditions.
With a dedicated team of licensed dietitian nutritionists and innovative technologies, MyOr promotes evidence-based practices and nutrition strategies that can prevent many chronic conditions. The company is committed to improving health outcomes and empowering healthcare providers and caregivers with personalized solutions to eliminate preventable conditions, creating a healthier future for our clients.
Funding history · 2 rounds · $5.5M total
2022-08
Series A
$5.0M
2018-04
Seed
$500K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient EngagementMedical Decision Support
Technologies
Artificial IntelligenceMachine Learning
Target customers
Financial ServicesFinancial ProductsInsuranceConsumersDemographics & FamilyChildrenHealthcare & Life SciencesHealthcareProviders
Business model
B2CB2B2C
Highlights
1 PatentsVerified
Tags
medical-devicesdigital-healthcareartificial-intelligencepersonalizationnutritionskin-caremachine-learningdigital-therapeuticsinsurance-companiespediatricschildrendermatologypharma-companiesbabiesactionable-insightspersonalized-medicinenon-invasivehealthcare-providerspredictive-analyticsimage-processingmonitoringpersonalized-treatment